PubRank

Xueqing Xia

Author PubWeight™ 20.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer. Cancer Res 2003 1.66
2 Interleukin-30: a novel antiinflammatory cytokine candidate for prevention and treatment of inflammatory cytokine-induced liver injury. Hepatology 2012 1.62
3 Universal marker and detection tool for human sarcoma circulating tumor cells. Cancer Res 2014 1.34
4 Sonoporation delivery of interleukin-27 gene therapy efficiently reduces prostate tumor cell growth in vivo. Hum Gene Ther 2011 1.17
5 Discovery of a linear peptide for improving tumor targeting of gene products and treatment of distal tumors by IL-12 gene therapy. Mol Ther 2011 1.14
6 Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy. J Natl Cancer Inst 2002 0.98
7 Expression of WSX1 in tumors sensitizes IL-27 signaling-independent natural killer cell surveillance. Cancer Res 2009 0.93
8 Stat1 deficiency in the host enhances interleukin-12-mediated tumor regression. Cancer Res 2006 0.91
9 A quantitative method for measuring gene expression magnitude and volume delivered by gene therapy vectors. Mol Ther 2004 0.89
10 Induction of IFN-regulated factors and antitumoral surveillance by transfected placebo plasmid DNA. Mol Ther 2005 0.89
11 Administering plasmid DNA encoding tumor vessel-anchored IFN-alpha for localizing gene product within or into tumors. Mol Ther 2008 0.85
12 Candidate genes associated with tumor regression mediated by intratumoral IL-12 electroporation gene therapy. Mol Ther 2004 0.82
13 Competitive DNA transfection formulation via electroporation for human adipose stem cells and mesenchymal stem cells. Biol Proced Online 2012 0.81
14 Safe and effective treatment of spontaneous neoplasms with interleukin 12 electro-chemo-gene therapy. J Cell Mol Med 2015 0.80
15 The mechanism of exogenous B7.1-enhanced IL-12-mediated complete regression of tumors by a single electroporation delivery. Int J Cancer 2006 0.80
16 WSX1 expression in tumors induces immune tolerance via suppression of effector immune cells. PLoS One 2011 0.80
17 Safety and efficacy of tumor-targeted interleukin 12 gene therapy in treated and non-treated, metastatic lesions. Curr Gene Ther 2015 0.79
18 CD8+T cell-specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8+T cell accumulation in tumors. Mol Cancer 2014 0.79
19 Generation of a monoclonal antibody against the glycosylphosphatidylinositol-linked protein Rae-1 using genetically engineered tumor cells. Biol Proced Online 2014 0.78
20 Managing local swelling following intratumoral electro-chemo-gene therapy. Methods Mol Biol 2014 0.77
21 Molecular imprint of enzyme active site by camel nanobodies: rapid and efficient approach to produce abzymes with alliinase activity. J Biol Chem 2012 0.76